EP
BIIB icon

Edgestream Partners’s Biogen BIIB Stock Holding History

Edgestream Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16,164
Closed -$2.03M – 876
2025
Q2 		$2.03M Sell
16,164
-686
-4% -$85.5K 0.06% 528
2025
Q1 		$2.31M Sell
16,850
-3,285
-16% -$470K 0.08% 447
2024
Q4 		$3.08M Buy
20,135
+8,917
+79% +$1.5M 0.13% 304
2024
Q3 		$2.17M Buy
11,218
+10,289
+1,108% +$2.15M 0.1% 378
2024
Q2 		$215K Sell
929
-721
-44% -$157K 0.01% 801
2024
Q1 		$356K Buy
+1,650
New +$386K 0.02% 694
2023
Q4 		– Sell
-4,386
Closed -$1.13M – 838
2023
Q3 		$1.13M Buy
+4,386
New +$1.17M 0.09% 362
2022
Q2 		– Sell
-6,375
Closed -$1.34M – 513
2022
Q1 		$1.34M Sell
6,375
-33,212
-84% -$7.22M 0.11% 278
2021
Q4 		$9.5M Buy
39,587
+22,373
+130% +$5.75M 0.59% 30
2021
Q3 		$4.87M Buy
17,214
+13,291
+339% +$4.36M 0.3% 110
2021
Q2 		$1.36M Buy
+3,923
New +$1.19M 0.08% 264
2018
Q4 		– Sell
-1,059
Closed -$374K – 227
2018
Q3 		$374K Sell
1,059
-5,409
-84% -$1.86M 0.06% 206
2018
Q2 		$1.88M Sell
6,468
-3,202
-33% -$900K 0.38% 98
2018
Q1 		$2.65M Buy
+9,670
New +$3M 0.52% 63
2015
Q2 		– Sell
-547
Closed -$231K – 108
2015
Q1 		$231K Buy
+547
New +$216K 0.3% 70
2014
Q3 		– Sell
-849
Closed -$268K – 80
2014
Q2 		$268K Buy
+849
New +$256K 0.17% 72

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Edgestream Partners's BIIB Position: Q3 2025 in Review

Edgestream Partners sold out of Biogen (BIIB) in Q3 2025, closing a stake of 16,164 shares — an estimated $2.03M sold.

Edgestream Partners first reported a position in BIIB in Q2 2014 and held it in 16 quarters. The position peaked at $9.5M in Q4 2021. 908 funds tracked by Wall St. Rank hold BIIB as of Q3 2025.

  • Edgestream Partners reported no remaining Biogen position as of Q3 2025 after selling out during the quarter.
  • Edgestream Partners sold 16,164 Biogen shares in Q3 2025, an estimated $2.03M.
  • Edgestream Partners first reported a position in Biogen in Q2 2014 and held it in 16 quarters.
  • Edgestream Partners's Biogen position peaked at $9.5M in Q4 2021.
  • 908 funds tracked by Wall St. Rank held Biogen as of Q3 2025.

Based on Edgestream Partners's 13F filing for Q3 2025, filed 12 Nov 2025.